Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D08ENB
|
|||
| Former ID |
DIB015662
|
|||
| Drug Name |
GSK1995057
|
|||
| Drug Type |
Antibody
|
|||
| Indication | Adult respiratory distress syndrome [ICD-11: CB00; ICD-10: J80; ICD-9: 518.5, 518.82] | Phase 1 | [1] | |
| Company |
Quark Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01587807) A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057. U.S. National Institutes of Health. | |||
| REF 2 | Autoantibodies to variable heavy (VH) chain Ig sequences in humans impact the safety and clinical pharmacology of a VH domain antibody antagonist of TNF-alpha receptor 1. J Clin Immunol. 2013 Oct;33(7):1192-203. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.